News
Some antibodies neutralize the virus effectively, while others bind only weakly. Pinpointing exactly which parts of a virus ...
Peter M. Voorhees, MD, shares key insights from the 2025 American Society of Clinical Oncology Annual Meeting, specifically in the multiple myeloma space.
At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a signal to the ...
Titer tests are what's used "to help you determine if you currently have immunity to certain diseases due to past infection or vaccination,” says Dr. Alison Mitzner, a New York board-certified ...
A team at Scripps Research has created a microchip that can rapidly reveal how a person's antibodies respond to viruses using only a drop of blood. This game-changing technology, called mEM, condenses ...
Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...
A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses—using just ...
The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.
T-bet is a transcription factor, one of the control proteins in the cell nucleus that can turn specific groups of genes on ...
A common hay fever trigger could be treated by placing a "molecular shield" in the nose within five years. Scientists have ...
XOMA Royalty’s acquisition of Turnstone Biologics highlights how royalty deals can revive biopharma companies and drive ...
1d
Clinical Trials Arena on MSNPDS Biotechnology completes recruitment for stage one of colorectal cancer trialThe trial is spearheaded by Dr Jonathan Hernandez, the surgical oncology section chief of the National Cancer Institute.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results